Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the complete record of transactions filed by Sharp Shalini, Director. Director active across 4 companies, notably Mirati Therapeutics, Inc.. Cumulatively, 11 disclosures have been logged. Activity tracked since 14 January 2022. The latest transaction was filed on 21 May 2025 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
11 of 11 declarations
Shalini Sharp serves as a Board Member at Mirati Therapeutics, Inc. She brings her expertise in corporate governance and strategy to the board. Shalini plays a key role in strategic decision-making and the future direction of the company, thereby contributing to its success in the biopharmaceutical sector.